Cargando…

Predicting Hearing Loss in Testicular Cancer Patients after Cisplatin-Based Chemotherapy

SIMPLE SUMMARY: To our knowledge, this is the first study that presents a machine learning setup incorporating genetics and clinical factors to predict hearing loss in a large and fairly unique cohort of testicular cancer patients, with follow-up data examining long-range side effects of chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia, Sara L., Lauritsen, Jakob, Christiansen, Bernadette K., Hansen, Ida F., Bandak, Mikkel, Dalgaard, Marlene D., Daugaard, Gedske, Gupta, Ramneek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417151/ https://www.ncbi.nlm.nih.gov/pubmed/37568739 http://dx.doi.org/10.3390/cancers15153923

Ejemplares similares

Prediction of Nephrotoxicity Associated With Cisplatin-Based Chemotherapy in Testicular Cancer Patients
por: Garcia, Sara L, et al.
Publicado: (2020)

A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention)
por: Bandak, Mikkel, et al.
Publicado: (2017)

Cohort Profile: The Danish Testicular Cancer Late Treatment Effects Cohort (DaTeCa-LATE)
por: Kreiberg, Michael, et al.
Publicado: (2018)

The Danish Testicular Cancer database
por: Daugaard, Gedske, et al.
Publicado: (2016)

Prognostic factors for relapse in patients with clinical stage I testicular cancer: protocol for a Danish nationwide cohort study
por: Wagner, Thomas, et al.
Publicado: (2019)

A Validated Algorithm for Register-Based Identification of Patients with Relapse of Clinical Stage I Testicular Cancer
por: Wagner, Thomas, et al.
Publicado: (2023)

At what price do we treat patients with testicular cancer?
por: Daugaard, Gedske
Publicado: (2013)

Neurological Adverse Effects after Radiation Therapy for Stage II Seminoma
por: Ebbeskov Lauritsen, Liv, et al.
Publicado: (2012)

Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database
por: Lauritsen, Jakob, et al.
Publicado: (2023)

Small RNAs in Seminal Plasma as Novel Biomarkers for Germ Cell Tumors
por: Mørup, Nina, et al.
Publicado: (2021)

A genome-wide association study of men with symptoms of testicular dysgenesis syndrome and its network biology interpretation
por: Dalgaard, Marlene D, et al.
Publicado: (2011)

Evaluation of Circulating miRNA Biomarkers of Testicular Germ Cell Tumors during Therapy and Follow-up―A Copenhagen Experience
por: Mørup, Nina, et al.
Publicado: (2020)

Danish translation and pilot testing of the European Organization for Research and Treatment of Cancer QLQ-TC 26 (EORTC QLQ-TC26) questionnaire to assess health-related quality of life in patients with testicular cancer
por: Bager, Louise, et al.
Publicado: (2018)

Association between polymorphisms in the aryl hydrocarbon receptor repressor gene and disseminated testicular germ cell cancer
por: Brokken, Leon J. S., et al.
Publicado: (2013)

Progressive Resistance Training and Cancer Testis (PROTRACT) - Efficacy of resistance training on muscle function, morphology and inflammatory profile in testicular cancer patients undergoing chemotherapy: design of a randomized controlled trial
por: Christensen, Jesper F, et al.
Publicado: (2011)

Genome-Wide Assessment of the Association of Rare and Common Copy Number Variations to Testicular Germ Cell Cancer
por: Edsgärd, Daniel, et al.
Publicado: (2013)

Optimized detection of germ cell neoplasia in situ in contralateral biopsy reduces the risk of second testis cancer
por: Rajpert‐De Meyts, Ewa, et al.
Publicado: (2022)

Thromboembolic events in metastatic testicular cancer treated with cisplatin-based chemotherapy
por: Shields, Lisa B E, et al.
Publicado: (2021)

Prevention and Restoration of Hearing Loss Associated with the Use of Cisplatin
por: Chirtes, Felician, et al.
Publicado: (2014)

Febrile Neutropenia and Long-term Risk of Infection Among Patients Treated With Chemotherapy for Malignant Diseases
por: Nordvig, Josefine, et al.
Publicado: (2018)

Sensorineural Hearing Loss after Combined Intensity Modulated Radiation Therapy and Cisplatin-Based Chemotherapy for Nasopharyngeal Carcinoma()()
por: Wang, Jin, et al.
Publicado: (2015)

Luteinizing Hormone Receptor Is Expressed in Testicular Germ Cell Tumors: Possible Implications for Tumor Growth and Prognosis
por: Lorenzen, Mette, et al.
Publicado: (2020)

Comprehensive Characterization of the Vascular Effects of Cisplatin-Based Chemotherapy in Patients With Testicular Cancer
por: Cameron, Alan C., et al.
Publicado: (2020)

Oral Administration of Caffeine Exacerbates Cisplatin-Induced Hearing Loss
por: Sheth, Sandeep, et al.
Publicado: (2019)

Dose-Dependent Effects of Resveratrol on Cisplatin-Induced Hearing Loss
por: Lee, Chang Ho, et al.
Publicado: (2020)

Astaxanthine attenuates cisplatin ototoxicity in vitro and protects against cisplatin-induced hearing loss in vivo
por: Nan, Benyu, et al.
Publicado: (2022)

Prediction of Febrile Neutropenia after Chemotherapy Based on Pretreatment Risk Factors among Cancer Patients
por: Aagaard, Theis, et al.
Publicado: (2017)

Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors
por: Fung, Chunkit, et al.
Publicado: (2018)

Advantages in Combination Chemotherapy Using Cisplatin and Its Analogues for Human Testicular Tumor Xenografts
por: Hida, Shuichi, et al.
Publicado: (1990)

How to Manage Cisplatin-Based Chemotherapy–Related Cardiovascular Disease in Patients With Testicular Cancer
por: Kadambi, Sindhuja, et al.
Publicado: (2022)

Progress in the Development of Preventative Drugs for Cisplatin-Induced Hearing Loss: Miniperspective
por: Hazlitt, Robert A., et al.
Publicado: (2018)

Thrombosis of abdominal aorta during cisplatin-based chemotherapy of testicular seminoma - a case report
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2009)

Association of metallothionein expression and clinical response to cisplatin based chemotherapy in testicular germ cell tumors
por: Tuzel, Emre, et al.
Publicado: (2015)

CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss
por: Teitz, Tal, et al.
Publicado: (2018)

Magnetic Nanoparticle Mediated Steroid Delivery Mitigates Cisplatin Induced Hearing Loss
por: Ramaswamy, Bharath, et al.
Publicado: (2017)

Absence of Relationship between Mitochondrial DNA Haplogroups and Cisplatin-Induced Hearing Loss
por: Graterol, D., et al.
Publicado: (2017)

Sulforaphane attenuates cisplatin-induced hearing loss by inhibiting histone deacetylase expression
por: Wang, Jie, et al.
Publicado: (2021)

Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy
por: Zhang, Xindi, et al.
Publicado: (2022)

Cancer therapy and risk of congenital malformations in children fathered by men treated for testicular germ-cell cancer: A nationwide register study
por: Al-Jebari, Yahia, et al.
Publicado: (2019)

1549. Development and Validation of a Cycle-Specific Risk Score for Febrile Neutropenia After Chemotherapy in Patients with Cancer: The (CSR)FENCE Score
por: Aagaard, Theis, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_iru9kqqogakb70l0rlnsip0bhf